All In Biotech

Drug Trial Radar · NCT07229807

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

A Phase 3 Study of ZSP1273 in Otherwise Healthy Children 2-11 Years Old With Influenza A

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Nov 22, 2025

Primary completion

Jan 17, 2026

Study completion Jan 21, 2026

Sponsor

Sponsor type
Industry
First posted
Nov 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 2 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules

Conditions

  • Influenza a

Interventions

  • ZSP1273Drug

    Oral

  • OseltamivirDrug

    Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Alleviation of SymptomsTime frame: DAY1~DAY15

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Children Hospital

    Beijing, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.